Department of Intensive Care Medicine, Chi Mei Medical Center, Yong-Kang Region, Tainan, Taiwan.
Respirology. 2012 Oct;17(7):1086-93. doi: 10.1111/j.1440-1843.2012.02214.x.
Population-based data on pleural infections are limited. This study describes the temporal trends in the incidence, management and outcomes of pleural infections in Taiwan.
The Taiwan National Health Insurance Research Database was used to analyse data on 26,385 patients with a first episode of pleural infection between 1997 and 2008.
During the study period, the median age of the patients increased from 60 to 65 years. The majority of patients were men (75%); this proportion remained constant over time. The standardized annual incidence of pleural infection increased from 5.2 per 100,000 in 1997 and reached a plateau of 8.4 to 9.6 per 100,000 between 2002 and 2008. Over time, there was an increase in the use of computed tomography (from 47.3% in 1997-1998 to 59.4% in 2007-2008), pigtail catheters (from 1.5% to 18.9%), fibrinolytics (from 0.9% to 9.3%) and surgery (from 27.7% to 33.6%), to treat pleural infections. Furthermore, the use of life-support resources, including haemodialysis, mechanical ventilation and intensive care, also increased by 3.1%, 11.0% and 12.8%, respectively. Median hospital charges per patient increased by 63.6% over the 12 years. Although the proportion of patients with organ dysfunction (i.e. severe sepsis) increased from 26.5% to 47.7%, 30-day mortality decreased from 15.0% to 13.1% (P-value for trend = 0.001).
These findings suggest that advances in the management of pleural infections and subsequent severe sepsis may have led to a reduction in the risk of short-term mortality in Taiwan.
关于胸膜感染的基于人群的数据十分有限。本研究旨在描述台湾胸膜感染的发病情况、处理方式和结局的时间趋势。
本研究使用了台湾全民健康保险研究数据库,分析了 1997 年至 2008 年间 26385 例初次发生胸膜感染患者的数据。
在研究期间,患者的中位年龄从 60 岁增加到了 65 岁。大多数患者为男性(75%),且这一比例随时间保持不变。胸膜感染的标准化年发病率从 1997 年的每 100000 人 5.2 例增加到 2002 年至 2008 年的每 100000 人 8.4-9.6 例,达到了一个平台期。随着时间的推移,CT 扫描(从 1997-1998 年的 47.3%增加到 2007-2008 年的 59.4%)、猪尾导管(从 1.5%增加到 18.9%)、纤维蛋白溶解剂(从 0.9%增加到 9.3%)和手术(从 27.7%增加到 33.6%)的使用率均有所上升。此外,血液透析、机械通气和重症监护等生命支持资源的使用率分别增加了 3.1%、11.0%和 12.8%。每位患者的中位住院费用在 12 年内增加了 63.6%。尽管器官功能障碍(即严重脓毒症)患者的比例从 26.5%增加到了 47.7%,但 30 天死亡率从 15.0%下降到了 13.1%(趋势 P 值<0.001)。
这些发现表明,胸膜感染处理方式的进步以及随后严重脓毒症的治疗可能降低了台湾地区胸膜感染患者短期死亡的风险。